Alexis Caulier: Leveraging Epigenetic Silencing in HSCs to Modulate Platelet Aggregation
Alexis Caulier, Assistant Professor, Department of Medicine at McGill University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cell Stem Cell, adding:
“Shoutout to the great Tianyi Ye from The Sankaran Lab for her fantastic work leveraging durable epigenetic silencing in HSCs to modulate platelet aggregation!
A new avenue to prevent cardio-vascular events in high-risk patients?”
Title: Durable and reversible epigenetic programming of human hematopoietic stem cells as a platform for modulation of platelet function
Authors: Tianyi Ye, Wanying Xu, Maria N. Barrachina, Peng Lyu, Mateusz Antoszewski, Lucrezia della Volpe, Chun-Jie Guo, Andrew J. Lee, Emily Villalpando, Isaac A. Johnson, Madelaine S. Theardy, Spencer D. Shelton, Lara Wahlster, Alexis Caulier, Luana Messa, Michael Poeschla, Gaurav Agarwal, Ronodeep Mitra, Alec A. Schmaier, Jonathan S. Weissman, Kellie R. Machlus, Vijay G. Sankaran
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 7, 2026, 15:34Salih Ehsan: Iron Deficiency Beyond Conventional Ferritin Cutoffs
-
Nov 7, 2026, 15:21Shamee Shastry: Improving the Reliability and Reproducibility of the Monocyte Monolayer Assay
-
Nov 7, 2026, 14:39AI-Assisted Donor Screening and Transfusion Decision Support: A Prospective Multicentre Evaluation
-
Nov 7, 2026, 14:26Qiong Tang: Changing Perspectives on Iron Deficiency and Supplementation
-
Nov 7, 2026, 14:21Nathan Connell: Bringing VWD Education Across Borders to Improve Patient Care
-
Nov 7, 2026, 14:02David McIntosh: Thalassaemia Care Needs More Than Breakthrough Therapies
-
Nov 7, 2026, 14:00Farzin Beygui: SOLOTAVI Tests Aspirin Discontinuation After TAVI
-
Nov 7, 2026, 13:50Edward Lee Carter: Is Aspirin Monotherapy Sufficient After Watchman Implantation?
-
Nov 7, 2026, 13:40Leticia Leal: Preventing Blood Clots During Long Flights